1371. The enhanced cytotoxic effects in B-cell leukemia and lymphoma following activation of prostaglandin EP4 receptor and targeting of CD20 antigen by monoclonal antibodiesTijana Markovič, Helena Podgornik, Damjan Avsec, Sanja Nabergoj, Irena Mlinarič-Raščan, 2022, original scientific article Keywords: B-cell leukemia and lymphoma, chronic lymphocytic leukemia, prostaglandin EP4 receptor, selective EP4 receptor agonist, monoclonal antibodies, synergistic effects Full text (file, 1,90 MB) This document has more files! More... |
1372. Sinergistično delovanje ibrutiniba in idelalisiba z agonisti receptorja EP4 na celicah kronične limfocitne levkemijeDamjan Avsec, 2018, master's thesis Keywords: kronična limfocitna levkemija, ibrutinib, fludarabin, sinergizem, idelalisib, L-902, 688, PgE1-OH, prostaglandinski receptor tipa 4 (Ep4) Full text (file, 2,62 MB) |
1373. A putative serine protease is required to initiate the RIPK3-MLKL—mediated necroptotic death pathway in neutrophilsXiaoliang Wang, Damjan Avsec, Aleš Obreza, Shida Yousefi, Irena Mlinarič-Raščan, Hans-Uwe Simon, 2021, original scientific article Keywords: necroptosis, neutrophil, serine protease, signal transduction, small molecule inhibitor Full text (file, 1,47 MB) This document has more files! More... |
1374. Inhibition of p38 MAPK or immunoproteasome overcomes resistance of chronic lymphocytic leukemia cells to Bcl-2 antagonist venetoclaxDamjan Avsec, Marja Škrlj, Tilen Burnik, Maša Kandušer, Maruša Bizjak, Helena Podgornik, Irena Mlinarič-Raščan, 2022, original scientific article Full text (file, 4,77 MB) This document has more files! More... |
1375. Vloga avtofagije pri odpornosti celic kronične limfocitne levkemije na zaviralce receptorske poti celic BŠpela Jelesijevič, 2022, master's thesis/paper Keywords: kronična limfocitna levkemija (KLL), odpornost na zdravljenje, ibrutinib, akalabrutinib, duvelizib, idelalizib, avtofagija, sinergizem Full text (file, 3,93 MB) This document has more files! More... |
|
|
1378. Sinergistično delovanje zaviralcev proteasoma in imunoproteasoma z zaviralci receptorske poti limfocitov B na celicah kronične limfocitne levkemijeTilen Burnik, 2022, master's thesis/paper Keywords: kronična limfocitna levkemija, konstitutivni proteasom, imunoproteasom, karfilzomib, ONX-0914, NFκB, sinergizem Full text (file, 2,96 MB) This document has more files! More... |
1379. Preučevanje mehanizmov odpornosti celic kronične limfocitne levkemije na sodobno terapijoAnđela Dragović, 2023, master's thesis/paper Keywords: kronična limfocitna levkemija, fosfatidilinozitol 3-kinaza, PI3K, NF-κB, idelalizib, duvelizib, proteasom, imunoproteasom, karfilzomib, ONX-0914, odpornost Full text (file, 3,33 MB) |
1380. The role of proteasome, immunoproteasome and autophagy in the therapy of chronic lymphocytic leukemiaDamjan Avsec, 2023, doctoral dissertation Keywords: CLL, proteasome, immunoproteasome, autophagy, targeted therapy, resistance, ibrutinib, idelalisib, venetoclax, NFκB, B-cell receptor Full text (file, 31,60 MB) |